U.S. markets open in 47 minutes
  • S&P Futures

    3,328.25
    -54.75 (-1.62%)
     
  • Dow Futures

    26,855.00
    -510.00 (-1.86%)
     
  • Nasdaq Futures

    11,423.00
    -165.00 (-1.42%)
     
  • Russell 2000 Futures

    1,557.30
    -31.70 (-1.99%)
     
  • Crude Oil

    37.76
    -1.81 (-4.57%)
     
  • Gold

    1,881.40
    -30.50 (-1.60%)
     
  • Silver

    23.75
    -0.82 (-3.32%)
     
  • EUR/USD

    1.1727
    -0.0062 (-0.53%)
     
  • 10-Yr Bond

    0.7580
    -0.0200 (-2.57%)
     
  • Vix

    36.85
    +4.39 (+13.52%)
     
  • GBP/USD

    1.2923
    -0.0118 (-0.91%)
     
  • USD/JPY

    104.4260
    -0.0680 (-0.07%)
     
  • BTC-USD

    13,222.96
    -487.05 (-3.55%)
     
  • CMC Crypto 200

    261.81
    +0.52 (+0.20%)
     
  • FTSE 100

    5,620.61
    -108.38 (-1.89%)
     
  • Nikkei 225

    23,418.51
    -67.29 (-0.29%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PROG, BMRN and GTX

·4 mins read

NEW YORK, NY / ACCESSWIRE / October 8, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Progenity, Inc. (NASDAQ:PROG)

This lawsuit is on behalf of all purchasers of Progenity common stock pursuant and/or traceable to the registration statement, as amended, issued in connection with Progenity's June 2020 initial public offering.

A class action has commenced on behalf of certain shareholders in Progenity, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) that Progenity had overbilled government payors by $10.3 million in 2019 and early 2020 and, thus, had materially overstated its revenues, earnings and cash flows from operations for the historical financial periods provided in the registration statement; (ii) that Progenity would need to refund this overpayment in the second quarter of 2020 (the same quarter in which the initial public offering was conducted), adversely impacting its quarterly results; and (iii) that Progenity was suffering from accelerating negative trends in the second quarter of 2020 with respect to the Company's testing volumes, revenues and product pricing.

Shareholders may find more information at https://securitiesclasslaw.com/securities/progenity-inc-loss-submission-form/?id=9936&from=1

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Investors Affected : February 28, 2020 - August 18, 2020

A class action has commenced on behalf of certain shareholders in BioMarin Pharmaceutical Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated virus gene therapy, limited the reliability of the Phase 1/2 study to support valoctocogene roxaparvovec's durability of effect; (ii) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the Biologics License Application for valoctocogene roxaparvovec without additional data; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/biomarin-pharmaceutical-inc-loss-submission-form/?id=9936&from=1

Garrett Motion Inc. (NYSE:GTX)

Investors Affected : October 1, 2018 - September 18, 2020

A class action has commenced on behalf of certain shareholders in Garrett Motion Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) due to its agreement to indemnify and reimburse Honeywell for certain asbestos-related liability, Garrett was saddled with an unsustainable level of debt; (2) as a result, Garrett had a highly leveraged capital structure that posed significant challenges to its overall strategic and financial flexibility; (3) as a result of the foregoing, Garrett's ability to gain or hold market share was impaired; (4) as a result of the foregoing, the Company was reasonably likely to seek bankruptcy protection; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/garrett-motion-inc-loss-submission-form/?id=9936&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/609826/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-PROG-BMRN-and-GTX